Dialectal Features Varied for Colorectal Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Colorectal CancerDialectal Features Varied - Behavioral
Eligibility
45 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial will explore whether people perceive a virtual health assistant to be more credible if it speaks with African American English linguistic features integrated at a low or high level, compared to Standardized American English linguistic features or text only.

Eligible Conditions
  • Colorectal Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 months

6 months
Credibility score

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Interaction with a VHA without voice
1 of 2
Interaction with a VHA with voice
1 of 2

Active Control

Experimental Treatment

750 Total Participants · 2 Treatment Groups

Primary Treatment: Dialectal Features Varied · No Placebo Group · N/A

Interaction with a VHA with voiceExperimental Group · 2 Interventions: Dialectal Features Varied, Video Intervention · Intervention Types: Behavioral, Behavioral
Interaction with a VHA without voice
Behavioral
ActiveComparator Group · 1 Intervention: VHA with no voice · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Video Intervention
2019
N/A
~40

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
39,236 Total Patients Enrolled
University of FloridaLead Sponsor
1,251 Previous Clinical Trials
698,063 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
171 Previous Clinical Trials
123,944 Total Patients Enrolled
Kevin TangPrincipal InvestigatorUniversity of Florida
Kevin Tang, PhDPrincipal InvestigatorUniversity of Florida
Janice Krieger, PhDPrincipal InvestigatorUniversity of Florida
2 Previous Clinical Trials
2,568 Total Patients Enrolled

Eligibility Criteria

Age 45 - 75 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: